SCHD vs. the Rate Scare: What the 2022 Playbook Actually Showed

In a recent analysis, Marc Guberti warns that SCHD's performance could falter if the 10-year Treasury yield surpasses 4.75%. However, historical data from 2022 reveals that SCHD, which focuses on strong cash-generating companies, outperformed the S&P 500 despite rising rates. This underscores the importance of distinguishing between dividend stocks that act as bond proxies and those like SCHD that prioritize value and cash flow. High-income professionals should consider SCHD's resilience

A widely-circulated 24/7 Wall St. piece by Marc Guberti lays out a clean-sounding warning: SCHD has surged in 2026, the 10-year Treasury is the variable that matters most, and if that yield breaks back above 4.75%, SCHD's leadership fades — just like it did in 2022.

The rate mechanics are real and worth respecting. But the 2022 analogy is where the argument turns on itself. That year is the single best test we have of whether SCHD trades like a bond proxy. It didn't.

Start With the Fund the Data Describes

SCHD — Price History
SCHD — Price History
SCHD — Sector Allocation
SCHD — Sector Allocation

SCHD tracks the Dow Jones U.S. Dividend 100 Index — a rules-based screen for companies with strong free cash flow, healthy balance sheets, and a track record of paying. At a 0.06% expense ratio and $95.2 billion in assets, it is a large-value fund, not a yield-maximizer. Its trailing yield is 3.25%.

That distinction is the whole ballgame. "Rising rates hurt dividend stocks" is true for sleeves whose appeal is a bond-like coupon — think regulated utilities and REITs, where cash flows are long-duration and interest-rate-sensitive. It is a much weaker statement about a screen that buys cheap, cash-generative businesses.

Performance and yield figures are historical and may change. Total return includes price movement and distributions where available. Past performance does not guarantee future results. Yield is not the same as total return.

The 2022 Test the Bear Case Invokes

The source names 2022 as its template: rising long yields hit dividend equities harder than the broad index because their cash flows "look more bond-like." So look at 2022.

SCHD vs SPY vs VYM vs XLU — Performance Comparison
SCHD vs SPY vs VYM vs XLU — Performance Comparison

This chart runs five years, from mid-2021 to today, computed on our own survivorship-free adjusted-close data. The 2022 segment is the one that matters for this debate. As the 10-year yield spiked through the year, SPY fell into a deep drawdown — roughly a fifth of its value at the 2022 lows. SCHD's decline over the same stretch was a fraction of that, and it finished 2022 far ahead of the S&P 500 on total return.

In other words, in the worst rate shock in 40 years, the fund the bear case says should have cracked was the one that held up. A bond proxy behaves like a bond when rates jump. SCHD didn't — because its screen tilts toward value, energy, and cash generation, which is the opposite of a duration-heavy income sleeve.

The honest other half of that chart: over the full five years, SPY's tech-led recovery from 2023 onward pulled its total return ahead of SCHD's. This isn't a story about SCHD always winning. It's a narrow, specific point — the one rate-shock year in recent memory is evidence against treating SCHD as rate-sensitive, not for it.

Where the Rate Risk Actually Lives

If you want to see rate-sensitive dividend exposure, look at what SCHD holds versus what a pure-yield or pure-utility sleeve holds. This is where the source's own logic points you — just not to SCHD.

Premium

Subscribe to Informed Investing

Subscribe free to read the full article — and unlock the complete archive.

We respect your inbox. Unsubscribe anytime.

We respect your inbox. Unsubscribe anytime.


Disclosure: This article is for informational and educational purposes only and is not financial, investment, tax, or legal advice. References to specific securities, tickers, companies, or strategies are provided for informational purposes only and do not constitute a recommendation, solicitation, or offer to buy or sell any security or financial product. We do not provide individualized advice or act as a fiduciary. Investing involves risk, including loss of principal, and past performance is not indicative of future results. We may hold positions in securities mentioned. You should independently verify information before acting on it and consult a qualified professional as needed.